泽生核心科技——学术论文

Ennequin, G., et al., Neuregulin 1 improves complex 2-mediated mitochondrial respiration in skeletal muscle of healthy and diabetic mice. Sci Rep, 2017. 7(1): p. 1742..
Caillaud, K., et al., Neuregulin 1 improves glucose tolerance in adult and old rats. Diabetes Metab, 2016. 42(2): p. 96-104.
Ennequin, G., et al., Neuregulin 1 affects leptin levels, food intake and weight gain in normal-weight, but not obese, db/dbmice. Diabetes Metab, 2015. 41(2): p. 168-72.
Ennequin, G., et al., Neuregulin 1 Improves Glucose Tolerance in db/db Mice. PLoS One, 2015. 10(7): p. e0130568.
Jabbour, A., et al., Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favo-urable acute and chronic haemodynamic responses. Eur J Heart Fail, 2011. 13(1): p. 83-92.
Xu Y, Li X, Liu X, et al. Neuregulin-1/ErbB signaling and chronic heart failure[J]. Advances in pharmacology, 2010, 59: 31-51.
Lai D, Liu X, Forrai A, et al. Neuregulin 1 Sustains the Gene Regulatory Network in Both Trabecular and Nontrabecular Myoca-rdiumNovelty and Significance[J]. Circulation research, 2010, 107(6): 715-727.
Gu X, Liu X, Xu D, et al. Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinasewith neuregulin[J]. Cardiovascular research, 2010, 88(2): 334-343.
Jiang Z, Zhou M. Neuregulin signaling and heart failure[J]. Current heart failure reports, 2010, 7(1): 42-47.
Gao R, Zhang J, Cheng L, et al. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-contr-olled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure[J]. Journal of the American College of Cardiology, 2010, 55(18): 1907-1914.
QI Y, Wei DZ, Liu X, Zhou M. Establishment of an ErbB3- and ErbB4-specific ligand screening system, and a screen of neuregulin-1 mutants[J]. HEREDITAS. 2010 (12) ):1247-1255.
Xu Y, Li X, Zhou M. Neuregulin-1/ErbB signaling: a druggable target for treating heart failure[J]. Current opinion in pharmacology, 2009, 9
Zhou M. The present and perspective polypeptide drugs development[J]. Biobusiness. 2009 (03):17-18.
Zhang X, Zhou M. Original new drugs in China, limits and forwards[J]. Science & Technology industry parks. 2007 (05):76-81.
Freedman N J, Ginsburg G S. Novel-and" neu"-therapeutic possibilities for heart failure[J]. JOURNAL-AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48(7): 1448.
Li Z, Mei Y, Liu X, et al. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners[J]. Cellular signalling, 2007, 19(3): 466-471.
Li Z, Mei Y, Liu X, et al. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners[J]. Cellular signalling, 2007, 19(3): 466-471.
Liu X, Gu X, Li Z, et al. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy[J]. Journal of the American College of Cardiology, 2006, 48(7): 1438-1447.
Luo C, Xu L, Zheng S, et al. Computational analysis of molecular basis of 1: 1 interactions of NRG‐1β wild‐type and variants with ErbB3 and ErbB4[J]. Proteins: Structure, Function, and Bioinformatics, 2005, 59(4): 742-756.
Liu X, Fernandez M, Wouters M A, et al. Arg1098 is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity[J]. Journal of Biological Chemistry, 2001, 276(36): 33518-33525.
Fernandez M, Liu X, Wouters M A, et al. Angiotensin I-converting Enzyme Transition State Stabilization by His1089 EVIDENCE FOR A CATALYTIC MECHANISM DISTINCT FROM OTHER GLUZINCIN METALLOPROTEINASES[J]. Journal of Biological Chemistry, 2001, 276(7): 4998-5004.
Li X, Zhang X, Lu Z, et al. Relative study of soluble syndecan-1 and prognosis of patients with multiple myeloma[J]. Journal of Chinese hematology, 2001, 22(6): 303-305.
Li X, Lu Z, Klein B. The expression, secretion and regulation of membrane-soluble syndecan-1 in human multiple myeloma cells[J]. Journal of Chinese hematology, 2000, 21(11): 572-576.
Liu X, Baker E, Eyre H J, et al. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation.[J]. Oncogene, 1999, 18(50): 7110-7114.
Klein B, Li X, Lu Z Y, et al. Activation Molecules on Human Myeloma Cells[J]. Current Topics in Microbiology and Immunology, 1999: 335-341.
Liu X, Hwang H H, Cao L, et al. Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95(22): 13024-13029.
Liu X, Hwang H H, Cao L, et al. Release of the Neuregulin Functional Polypeptide Requires Its Cytoplasmic Tail[J]. Journal of Biological Chemistry, 1998, 273(51): 34335-34340.
Cao L, Zhang L, Ruizlozano P, et al. A Novel Putative Protein-tyrosine Phosphatase Contains a BRO1-like Domain and Suppresses Ha-ras-mediated Transformation[J]. Journal of Biological Chemistry, 1998, 273(33): 21077-21083.
Li X, Zhang X, Zhang Y. Establishment of a novel culture system for specific expansion of human gamma delta T cell and study of its biological properties[J]. Journal of Chinese Medical, 1997, 77(2): 111-114.
Zhou M D, Sucov H M, Evans R M, et al. Retinoid-dependent pathways suppress myocardial cell hypertrophy[J]. Proceedings of the National Academy of Sciences of the United States of America, 1995, 92(16): 7391-7395.
Zhou M D, Goswami S K, Martin M E, et al. A new serum-responsive, cardiac tissue-specific transcription factor that recognizes the MEF-2 site in the myosin light chain-2 promoter.[J]. Molecular and Cellular Biology, 1993, 13(2): 1222-1231.
Qasba P, Lin E, Zhou M D, et al. A single transcription factor binds to two divergent sequence elements with a common function in cardiac myosin light chain-2 promoter[J]. Molecular and cellular biology, 1992, 12(3): 1107-1116.
Zhou M D, Ye W, Ashok K, et al. Mechanism of tissue-specific transcription: interplay between positive and negative regulatory factors[J]. Gene expression, 1992, 2(2): 127-138.

地址:上海市浦东张江高科技园区居里路68号沪ICP备06030993号